Contact this trialFirst, we need to learn more about you.
Stem Cell Transplantation
MGTA-456 for High-Risk Cancer
Recruiting3 awardsPhase 2
Minneapolis, Minnesota
This trial is testing whether expanding stem cells from umbilical cord blood in culture with cytokines can improve lympho-hematopoietic recovery after a myeloablative conditioning.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.